🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Imagine if your patients had their implant cards sent to their #iPhone immed’ly after their #RadialFirst coronary stent or #TAVR? Implants stored forever with legible, durable, transferable data that may prove essential. Stent size/length & serial number on back!

First commercial case of transcatheter mechanical leaflet laceration with ShortCut in the World performed at Atlantic Health ! Bilateral leaflet splitting in <15 minutes to facilitate ViV Happy to be able to offer multiple options for leaflet modification to our patients

🚨 𝗕𝗥𝗘𝗔𝗞𝗜𝗡𝗚 𝗡𝗘𝗪𝗦 🚨 𝗦𝗵𝗼𝗿𝘁𝗖𝘂𝘁 𝗶𝘀 𝗼𝗳𝗳 𝘁𝗼 𝗮𝗻 𝗶𝗻𝗰𝗿𝗲𝗱𝗶𝗯𝗹𝗲 𝘀𝘁𝗮𝗿𝘁 𝗶𝗻 𝘁𝗵𝗲 𝗨𝗦! 🚀 The first week of commercialization demonstrated strong demand, with leading structural heart centers successfully treating patients with #ShortCut,

📡░ L̾i̾v̾e̾ ̾f̾r̾o̾m̾ ̾N̾e̾w̾ ̾y̾o̾r̾k̾ ░📡 Coming to you from the Cardiovascular Research Foundation studios Upstream treatment of AS Marty Leon Philippe Genereux PCI & TAVR Dr. Jeffrey W. Moses Sripal Bangalore

Lucky to sit down with Philippe Genereux to discuss new insights from the EARLY TAVR trial and the incidence and impact of Acute Valve Syndrome Will be interesting to see how this data affects the management of AS and timing of TAVR moving forward American College of Cardiology #ACC25

Andrew, so nice to discuss with you! Thanks for the time you spent with me! a lot of learning with Early TAVR and the management of patients with Asymptomatic severe AS. Acute Valve Syndrome (AVS) is real and associated with poor outcomes…we have to do better!

What could be better than watching your two mentees presenting their scientific work in a single featured scientific session #ACC25 ⁦American College of Cardiology⁩ ⁦Philippe Genereux⁩ #EARLYTAVR Dr Marco Mennuni #ARISE #PayitFoward it feels good 😊

"These findings provide a strong rationale for prompt intervention in patients with asymptomatic severe aortic stenosis," explains Philippe Genereux. EARLY TAVR subanalysis showing that waiting until symptoms develop before TAVI leads to worse outcomes. tctmd.com/news/early-tav…

A glimpse to the present and future with an iCOACH session on TAV in TAV with great colleagues TCTME+ Mohammed Chamsi Pasha, FACC, FASE Musa A. Sharkawi Cardiovascular Research Foundation

First-in-human percutaneous transseptal Retrieveal of Embolized TRanscatheter valve In the lEft VEntricle (RETRIEVE) Now in press in JACC CVI Thank you to the patient/family and the Morristown team for the trust and support in me for this great save. Philippe Genereux

Exploring the Economic Impact of Cardiac Damage in Aortic Valve Replacement Patients: A Real-World Data Analysis | Circulation: Cardiovascular Interventions ahajournals.org/doi/10.1161/CI…. My editorial with Dr. Gilbert Tang in Circulation on Philippe Genereux Gennaro Giustino, MD ‘s article

A victory for early treatment: FDA approves #TAVR in asymptomatic patients for the first time #cardiology Edwards Lifesciences Philippe Genereux #TAVR #TAVI #earlytavr ow.ly/WHN050VLlG0

🚨Presented at #SCAI2025 - Meta-analysis shows pre-emptive #aortic #valve replacement in asymptomatic severe #AorticStenosis significantly reduces all-cause mortality, CV mortality, & unplanned CV/#HF hospitalizations vs clinical surveillance. Read more:

Sunil V. Rao Gregg W. Stone MD Gennaro Giustino, MD David Kandzari Philippe Genereux chris metzger

Congrats Gennaro Giustino, MD from Atlantic Health for this superb presentation Late-Breaking trial at SCAI! Pedro Villablanca MD, MSc, FACC, FSCAI Sunil V. Rao Gregg W. Stone MD

Sunil V. Rao Gregg W. Stone MD Gennaro Giustino, MD David Kandzari Philippe Genereux chris metzger 🏥Breaking: results from the Early TAVR #Trial look at the impact of age on procedural timing for asymptomatic severe aortic stenosis. Read the abstract by Philippe Genereux ➡️ scai.confex.com/scai/2025/meet… #SCAI2025 #LateBreaking #Cardiology #Research #InterventionalCardiology #CardioX

Latest EARLY TAVR data: Cardiac damage was frequent in pts enrolled in the trial of TAVI in asymptomatic AS, with those treated preemptively more likely to show an improvement in their stage of clinical damage Philippe Genereux #EuroPCR

Novel concept related to the severity and acuity of clinical presentation among patients with Aortic Stenosis just published in Circulation ! Acute Valve Syndrome #AVS has important prognosis implication before AVR. ahajournals.org/doi/10.1161/CI… Philippe Pibarot Victoria Delgado

#OnMyMind: A new clinical classification for aortic stenosis—stable, progressive, and acute valve syndromes—captures distinct presentation patterns with prognostic value. Recognizing acute presentations ... #AHAJournals Philippe Genereux Vanderbilt Structural Heart & Valve Center Philippe Pibarot ahajrnls.org/4mUVGkf

Agree! ahajournals.org/doi/10.1161/CI… AVS (Acute Valve Syndrome) represents 70% of the AVR performed in USA…we can do better! Early detection of AS, early referral to heart team for CTA assessment, and prompt AVR is key!